ISZO Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XPEL
XPEL
|
+$12.8M |
| 2 |
Forte Biosciences
FBRX
|
+$2.29M |
| 3 |
NTP
Nam Tai Property Inc.
NTP
|
+$6.69K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$1.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 45.47% |
| 2 | Healthcare | 32.3% |
| 3 | Consumer Discretionary | 22.23% |
Similar funds
ISZO Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, ISZO Capital Management held 4 positions worth $75.6M, up 18% from $64M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
ISZO Capital Management deployed $13.6M of net new capital in Q3 2019, opening 2 new positions and adding to 1 existing holding. Its largest new stake was XPEL: 1,423,393 shares worth $16.8M.
By sector, the portfolio is most concentrated in Real Estate at 45% of assets, down from 58% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Avid Bioservices, Inc. Common Stock, an estimated $1.51M trimmed.
- ISZO Capital Management's largest Q3 2019 buy was XPEL: 1,423,393 shares worth $16.8M.
- ISZO Capital Management added most to Nam Tai Property Inc. in Q3 2019, an estimated $6.69K increase.
- ISZO Capital Management's biggest Q3 2019 reduction was Avid Bioservices, Inc. Common Stock, cutting an estimated $1.51M.
- ISZO Capital Management's ten largest holdings make up 100% of its $75.6M portfolio in Q3 2019.
- ISZO Capital Management opened 2 new positions and closed 0 in Q3 2019.
- ISZO Capital Management's portfolio value rose 18% quarter-over-quarter to $75.6M.
Based on ISZO Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.